Kelly Jared (CIK 2103581) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-13). Recent activity: Buy ONCY (5,050 shares), Buy ONCY (5,600 shares), Buy ONCY (29,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-13 | ONCOLYTICS BIOTECH INC (ONCY) | Chief Executive Officer | Buy | 5,050 | $4,848 |
| 2026-02-13 | ONCOLYTICS BIOTECH INC (ONCY) | Chief Executive Officer | Buy | 5,600 | $4,704 |
| 2026-02-13 | ONCOLYTICS BIOTECH INC (ONCY) | Chief Executive Officer | Buy | 29,500 | $24,780 |
Source: SEC Form 4 filings · as of 2026-03-13